You are here

  • Home
  • Archive
  • Volume 1, Issue 1
  • An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity

Citation Tools

Article menu

Download PDFPDF

XML
Lung cancer
An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Minchom AR, Saksornchai K, Bhosle J, et al
An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicity
BMJ Open Respiratory Research 2014;1:e000061. doi: 10.1136/bmjresp-2014-000061